Kaplan Thaler Wins $80 Mil. Celebrex

Be among trailblazing marketing pros at Brandweek this September 23–26 in Phoenix, Arizona. Experience incredible networking, insightful sessions and a boost of inspiration at ADWEEK’s ultimate brand event. Register by May 13 to save 35%.

NEW YORK Pfizer has selected Publicis Groupe’s Kaplan Thaler Group to handle creative duties for its Celebrex pain relief brand, the client has confirmed. Billings are estimated at $80 million.

The decision came after a three-month review in which the finalists were Havas’ Arnold and Kaplan Thaler, both in New York. Kaplan Thaler in July won creative duties on the client’s Zoloft brand after a review.

Dorothy Wetzel, vice president of U.S. consumer marketing for Pfizer, confirmed hiring Kaplan Thaler but declined further comment.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Subscribe today!

To Read the Full Story Become an Adweek+ Subscriber

View Subscription Options

Already a member? Sign in